BeiGene Biotech-B (02315) rose more than 11% to HK$63.65, moving above its 20-day moving average of HK$62.785, according to ETNet data.

The trading volume reached 831,000 shares, with a turnover of HK$50.78 million.

The gain marks two consecutive sessions higher, bringing the total increase to 12.9%.